Your browser doesn't support javascript.
loading
ABO Blood Groups and Incidence of COVID-19 in the Mass Gathering Events in Borriana (Spain), March 2020: A Retrospective Cohort Study.
Domènech-Montoliu, Salvador; Puig-Barberà, Joan; Guerra-Murcia, Olga; Pac-Sa, María Rosario; Orrico-Sanchéz, Alejandro; Gómez-Lanas, Lorna; Sala-Trull, Diego; Domènech-Leon, Carmen; Del Rio-González, Alba; Sánchez-Urbano, Manuel; Satorres-Martinez, Paloma; Latorre-Poveda, Marta; Ferrando-Rubert, Sara; Aparisi-Esteve, Laura; Badenes-Marques, Gema; Blasco-Gari, Roser; Casanova-Suarez, Juan; Fontal-Carcel, María; Gil-Fortuño, María; Hernández-Pérez, Noelia; Jovani-Sales, David; López-Diago, Laura; Notari-Rodríguez, Cristina; Pérez-Olaso, Oscar; Romeu-Garcia, María Angeles; Ruíz-Puig, Raquel; Arnedo-Pena, Alberto.
Afiliación
  • Domènech-Montoliu S; Emergency Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Puig-Barberà J; Vaccines Research Unit, Fundación Para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO-Public Health, 46020 Valencia, Spain.
  • Guerra-Murcia O; Vaccines Research Unit, Fundación Para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO-Public Health, 46020 Valencia, Spain.
  • Pac-Sa MR; Public Health Center, 12003 Castelló de la Plana, Spain.
  • Orrico-Sanchéz A; Vaccines Research Unit, Fundación Para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO-Public Health, 46020 Valencia, Spain.
  • Gómez-Lanas L; Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
  • Sala-Trull D; Universidad Católica de Valencia San Vicente Mártir, 46001 Valencia, Spain.
  • Domènech-Leon C; Emergency Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Del Rio-González A; Emergency Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Sánchez-Urbano M; Universidad CEU Cardenal Herrera, 12006 Castelló de la Plana, Spain.
  • Satorres-Martinez P; Health Centers I and II, 12530 Borriana, Spain.
  • Latorre-Poveda M; Emergency Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Ferrando-Rubert S; Emergency Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Aparisi-Esteve L; Emergency Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Badenes-Marques G; Emergency Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Blasco-Gari R; Carinyena Health Center, 12540 Vila-real, Spain.
  • Casanova-Suarez J; Emergency Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Fontal-Carcel M; Emergency Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Gil-Fortuño M; Nursing Service University Hospital de la Plana, 12548 Vila-real, Spain.
  • Hernández-Pérez N; Health Center, 12600 La Vall d'Uixó, Spain.
  • Jovani-Sales D; Microbiology Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • López-Diago L; Microbiology Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Notari-Rodríguez C; Emergency Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Pérez-Olaso O; Clinical Analysis Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Romeu-Garcia MA; Emergency Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Ruíz-Puig R; Microbiology Service University Hospital de la Plana, 12540 Vila-real, Spain.
  • Arnedo-Pena A; Public Health Center, 12003 Castelló de la Plana, Spain.
Epidemiologia (Basel) ; 4(1): 63-73, 2023 Jan 28.
Article en En | MEDLINE | ID: mdl-36810454
ABSTRACT
Our objective was to estimate the incidence of COVID-19 and the ABO blood Groups in the mass-gathering events (MGEs) during the Falles Festival in Borriana (Spain) from 6-10 March 2020. We conducted a population-based retrospective cohort study and measured anti-SARS-CoV-2 antibodies and the ABO of participants. We performed laboratory COVID-19 tests and obtained the ABO in 775 subjects (72.8% of the original exposed cohort) O-group (45.2%), A-group (43.1%), B-group (8.5%) and AB-group (3.4%). Adjusted for confounding factors, including COVID-19 exposure during the MGEs, attack rates of COVID-19 for each ABO group were 55.4%, 59.6%, 60.2%, and 63.7%. The adjusted relative risks were for O-group 0.93 (95% Confidence Interval [CI] 0.83-1.04), for A-group 1.06 (95% CI 0.94-1.18), for B-group 1.04 (95%CI 0.88-1.24), and for AB-group 1.11 (95% CI 0.81-1.51) with no significant differences.

Conclusions:

Our results suggest no effect of ABO on COVID-19 incidence. We observed weak but not significant protection of the O-group and not a significantly greater infection risk for the remaining groups compared with the O-group. More studies are needed to resolve the controversies regarding the association between ABO and COVID-19.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Epidemiologia (Basel) Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Epidemiologia (Basel) Año: 2023 Tipo del documento: Article País de afiliación: España